Show simple item record

dc.contributor.authorMolina García, Mariola
dc.contributor.authorFraguas, David
dc.contributor.authorDel Rey Mejías, Ángel
dc.contributor.authorMezquida, Gisela
dc.contributor.authorSánchez Torres, Ana M.
dc.contributor.authorAmoretti, Silvia
dc.contributor.authorLobo, Antonio
dc.contributor.authorGonzález Pinto Arrillaga, Ana María ORCID
dc.contributor.authorAndreu Bernabeu, Álvaro
dc.contributor.authorCorripio, Iluminada
dc.contributor.authorVieta, Eduard
dc.contributor.authorBaeza, Inmaculada
dc.contributor.authorMané, Anna
dc.contributor.authorCuesta, Manuel
dc.contributor.authorde la Serna, Elena
dc.contributor.authorPayá, Beatriz
dc.contributor.authorZorrilla Martínez, Iñaki
dc.contributor.authorArango, Celso
dc.contributor.authorBernardo, Miquel
dc.contributor.authorRapado-Castro, Marta
dc.contributor.authorParellada, Mara
dc.date.accessioned2021-06-21T12:03:03Z
dc.date.available2021-06-21T12:03:03Z
dc.date.issued2021-06-02
dc.identifier.citationJournal of Clinical Medicine 10(11) : (2021) // Article ID 2474es_ES
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10810/51968
dc.description.abstractBackground: premorbid IQ (pIQ) and age of onset are predictors of clinical severity and long-term functioning after a first episode of psychosis. However, the additive influence of these variables on clinical, functional, and recovery rates outcomes is largely unknown. Methods: we characterized 255 individuals who have experienced a first episode of psychosis in four a priori defined subgroups based on pIQ (low pIQ < 85; average pIQ ≥ 85) and age of onset (early onset < 18 years; adult onset ≥ 18 years). We conducted clinical and functional assessments at baseline and at two-year follow-up. We calculated symptom remission and recovery rates using the Positive and Negative Symptoms of Schizophrenia Schedule (PANSS) and the Global Assessment Functioning (GAF or Children-GAF). We examined clinical and functional changes with pair-wise comparisons and two-way mixed ANOVA. We built hierarchical lineal and logistic regression models to estimate the predictive value of the independent variables over functioning or recovery rates. Results: early-onset patients had more severe positive symptoms and poorer functioning than adult-onset patients. At two-year follow-up, only early-onset with low pIQ and adult-onset with average pIQ subgroups differed consistently, with the former having more negative symptoms (d = 0.59), poorer functioning (d = 0.82), lower remission (61% vs. 81.1%), and clinical recovery (34.1% vs. 62.2%). Conclusions: early-onset individuals with low pIQ may present persistent negative symptoms, lower functioning, and less recovery likelihood at two-year follow-up. Intensive cognitive and functional programs for these individuals merit testing to improve long-term recovery rates in this subgroup.es_ES
dc.description.sponsorshipThis work was supported by the Spanish Ministry of Science and Innovation. Instituto de Salud Carlos III, PI02/1248, PI03032, PI05/0678, PI08/0208 PI09/01442, PI11/00325, PI12/1303, PI14/00612, PI15/00723, PI17/009977, PI18/00753 cofinanced by ERDF Funds from the European Commission, “A way of making Europe”, CIBERSAM. Madrid Regional Government (B2017/BMD-3740 AGES-CM-2). The CERCA Program/Generalitat de Catalunya And Secretaria d’Universitats i Recerca del Departament d’Economia I Coneixement (2017SGR1355). Departament de Salut de la Generalitat de Catalunya, en la convocatoria corresponent a l’any 2017 de concessió de subvencions del Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020, modalitat Projectes de recerca orientats a l’atenció primària, amb el codi d’expedient SLT006/17/00345. European Union Structural Funds. European Union Seventh Framework Program under grant agreements FP7-HEALTH-2009-2.2.1-2-241909 (Project EU-GEI), FP7-HEALTH-2009-2.2.1-3-242114 (Project OPTiMISE), FP7-HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and FP7-HEALTH-2013-2.2.1-2-602478 (Project METSY); and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No 115916, Project PRISM, and grant agreement No 777394, Project AIMS-2-TRIALS), Fundación Familia Alonso, Fundación Alicia Koplowitz and Fundación Mutua Madrileña.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/603196es_ES
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/602478es_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/115916es_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/777394es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.subjectpsychosises_ES
dc.subjectfirst episodees_ES
dc.subjectpremorbid intelligencees_ES
dc.subjectage at onsetes_ES
dc.subjectfunctional outcomees_ES
dc.subjectremissiones_ES
dc.subjectrecoveryes_ES
dc.subjectheterogeneityes_ES
dc.subjectsubgroupes_ES
dc.titleThe Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2021-06-10T13:47:55Z
dc.rights.holder2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/2077-0383/10/11/2474/htmes_ES
dc.identifier.doi10.3390/jcm10112474
dc.contributor.funderEuropean Commission
dc.departamentoesNeurociencias
dc.departamentoeuNeurozientziak


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).